In June, JPMorgan's analysts released their latest top investment picks, reflecting a robust end to May with U.S. stocks reaching record highs, particularly driven by technology companies. The S&P 500 rose 5%, the Nasdaq Composite increased by over 8%, and the Dow Jones Industrial Average gained 3%. This month, JPMorgan added Viasat, a satellite communications provider, to its recommendations.
Viasat has experienced a remarkable 730% increase in its stock price over the past year, although it recently faced a 16% drop after announcing a shelf registration with the SEC to sell stock or debt. Despite this volatility, Needham has maintained a buy rating on Viasat and raised its price target significantly from $58 to $90.
Additionally, Eli Lilly continues to perform well, bolstered by its return to vaccine development and the restoration of coverage for its weight loss drug Zepbound by CVS Health, further solidifying its market position against competitors like Novo Nordisk.
Lilly's stock recently reached an all-time high, reflecting strong investor confidence amid its substantial market capitalization and recent acquisitions